Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.78% | 15.90% | 15.19% | 17.49% | 13.87% |
| Total Other Revenue | 26.33% | -36.02% | 163.86% | -18.78% | 1,609.09% |
| Total Revenue | 13.88% | 15.35% | 15.76% | 17.28% | 14.73% |
| Cost of Revenue | 4.95% | 12.64% | 12.35% | 21.59% | 17.51% |
| Gross Profit | 18.40% | 16.67% | 17.47% | 15.21% | 13.38% |
| SG&A Expenses | 50.91% | 12.50% | 14.31% | 42.46% | -12.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.86% | 15.64% | 16.08% | 35.47% | 1.81% |
| Operating Income | -76.12% | 10.86% | 10.51% | -123.79% | 383.53% |
| Income Before Tax | 12.75% | -5.52% | 148.57% | -117.25% | 80.76% |
| Income Tax Expenses | 78.59% | 146.32% | 113.30% | -129.55% | 206.22% |
| Earnings from Continuing Operations | -80.89% | -26.46% | 155.21% | -116.21% | 14.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 81.59% | 34.93% | -95.39% | 112.69% | 5.78% |
| Net Income | -80.58% | -22.59% | 190.30% | -118.30% | 26.11% |
| EBIT | -76.12% | 10.86% | 10.51% | -123.79% | 383.53% |
| EBITDA | -63.59% | 5.34% | 17.38% | -92.12% | 287.34% |
| EPS Basic | -81.94% | -27.27% | 159.74% | -116.81% | 44.00% |
| Normalized Basic EPS | -63.76% | 6.35% | 192.86% | -122.98% | 738.46% |
| EPS Diluted | -81.43% | -26.92% | 157.14% | -128.17% | 40.00% |
| Normalized Diluted EPS | -61.79% | 11.49% | 200.00% | -134.26% | 478.85% |
| Average Basic Shares Outstanding | 6.78% | 5.89% | 3.58% | 0.73% | 0.29% |
| Average Diluted Shares Outstanding | 1.40% | 0.89% | -0.77% | -32.37% | 45.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |